Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo.
暂无分享,去创建一个
Melvin J. Yu | E. Schuck | Yongbo Hu | Karen Tendyke | M. Towle | Y. Jiang | Huiming Zhang | Hong-jian Du | B. Littlefield | Vipul Kumar | S. Narayan | W. Zheng | H. Cheng | B. M. Seletsky | Eric M Carlson | K. Condon | P. Saxton | Sean T. Eckley | B. Lewis